Are electronic signatures legally binding?

Yes. Electronic signatures meet legal validity under the ESIGN Act (15 U.S.C. §7001) and UETA where adopted, provided intent, consent, attribution, and reliable record retention are present.

Do I need a BAA for e-signatures?

If the signature process will handle protected health information, a Business Associate Agreement is required under HIPAA prior to using a vendor for signing PHI.

Who must sign the policy?

Authorized organizational leaders—typically the medical director, pharmacy director, and chief compliance officer—should sign to evidence approval and accountability.

How often should the policy be reviewed?

Review at least annually or sooner after regulatory changes, sentinel events, audits, or major changes in prescribing practice or technology.

What if a state requires additional steps?

Incorporate state-specific requirements such as PDMP query rules and reporting thresholds; consult state boards or counsel for mandated actions.

How do I revoke or update a signed policy?

Issue a formally dated revision, obtain required approvals, and retain prior versions in the archive; communicate changes and retrain staff as needed.

Electronic Signature
Templates
Healthcare
Healthcare Narcotics Policy

Healthcare Narcotics Policy

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE NARCOTICS POLICY

Patient Name: Date of Birth: Medical Record #:

Patient Information

Address Phone Emergency Contact (Name and Phone)

Insurance Information

Insurance Provider Policy Number Group Number Subscriber Name

Medical History

Current Prescription Medications (include dose and frequency) Allergies / Adverse Reactions Prior Surgeries / Hospitalizations Chronic Medical Conditions

Purpose and Scope

This Narcotics Policy governs the prescribing, dispensing, monitoring and discontinuation of opioid and other controlled substances provided by this clinic. It applies to any patient who receives such medications from the clinic and outlines the obligations of the patient, the prescriber and the clinic for the safe and lawful use of controlled medications.

Prescribing Conditions and Informed Consent

Prescriptions for narcotic medications will be provided only after a clinical evaluation establishes that such therapy is medically necessary. Alternative treatments and non-opioid therapies will be considered. The prescriber will review expected benefits, potential risks including dependence, overdose, sedation and respiratory depression, and interactions with other substances such as alcohol and benzodiazepines.

Prescribing Provider: Clinic / Facility:

Patient Responsibilities

The patient agrees to the following conditions as necessary for continued prescribing of controlled substances:

I will use a single pharmacy for all prescriptions for controlled substances and will notify the clinic if I change pharmacies.
I consent to periodic urine or other drug screening and pill counts as requested by the prescriber.
I understand that early refills will not be provided for lost, stolen, or wasted medication and that refills require timely, documented clinical visits.
I will not share, sell, or permit others to use my medication and I will keep medications in a secure location.
I will promptly inform the prescriber of any side effects, new medications, or other prescribers treating me for pain or mental health conditions.

Monitoring, Compliance and Reporting

The clinic may review prescription records and other medical records, and may query prescription history databases in accordance with law to verify medication history. Noncompliance with this policy, evidence of diversion, repeated early refill requests, illicit drug use or unsafe use may result in tapering or discontinuation of controlled medications and referral for further evaluation.

I authorize the clinic and prescriber to communicate with my pharmacy(s) and other healthcare providers regarding my prescriptions and care: Authorize

Refill, Lost or Stolen Medication

Refills will be provided only in accordance with the prescriber's instructions and documented clinical need. Lost or stolen medications are not routinely replaced. Excessive or pattern-based requests for replacement may result in termination of controlled medication therapy.

Tapering and Discontinuation

The prescriber may initiate a taper or discontinue narcotic therapy when risks outweigh benefits, when there is evidence of misuse, when treatment goals are not met, or when required by clinical judgment. Emergency discontinuation may occur if continued therapy poses an immediate risk to the patient or others.

Authorization and Release

By signing below, I authorize the prescriber and clinic staff to obtain and review my prescription history and relevant medical records from other providers or pharmacies as necessary to manage controlled medication therapy. This authorization expires on:

Consequences and Legal Compliance

Failure to adhere to this policy may result in discontinuation of controlled medications, discharge from the clinic's controlled medication program, reporting to law enforcement where diversion is suspected, and other actions permitted by law and professional standards.

Patient Acknowledgment

I acknowledge that I have read and understand the Healthcare Narcotics Policy. I have had the opportunity to ask questions and have received answers. I accept the responsibilities described herein and agree to comply with this policy.

I acknowledge and understand the policy.
I acknowledge that I have been informed of the risks and alternatives to narcotic therapy.
I understand the potential consequences for noncompliance with this policy.

If signing on behalf of the patient, indicate relationship

Patient Printed Name:

Signature:

Date:

What a Healthcare Narcotics Policy Covers

A Healthcare Narcotics Policy is an institutional document that establishes standards for prescribing, dispensing, storing, auditing, and reporting controlled substances within a medical facility. It sets roles and responsibilities for prescribers, pharmacists, nurses, and compliance staff, addresses diversion prevention and controlled-substance inventory, and outlines documentation, retention, and incident-reporting procedures to meet federal and state regulatory expectations.

Why a Clear Policy Matters for Patient Safety and Compliance

A written narcotics policy reduces diversion risk, clarifies staff duties, supports defensible prescribing practices, and helps facilities meet regulatory duties under federal and state controlled-substance laws and applicable privacy rules such as HIPAA.

Who Needs to Create or Follow This Policy

The policy is typically created by leadership and used by clinical and administrative staff across the facility.

Hospital compliance officers and risk managers responsible for policy oversight and regulatory reporting.
Physicians, nurse practitioners, and physician assistants who prescribe controlled substances in clinical settings.
Pharmacists and nursing leadership who manage dispensing, storage, and inventory reconciliation.

All personnel listed in the policy should receive training and sign acknowledgements to document understanding and acceptance.

Core Sections to Include in a Professional Policy

A complete policy organizes expectations into discrete sections so staff can find and follow procedures consistently.

Scope

Defines which sites, services, and personnel the policy covers, and clarifies applicability to inpatient, outpatient, and telehealth encounters.

Definitions

Provides clear definitions for controlled-substance schedules, diversion, inventory reconciliation, and roles such as prescriber, dispenser, and custodian of records.

Prescribing Controls

Sets limits on initial and refill prescriptions, PDMP checks, documentation required for controlled prescriptions, and clinical justification for high-dose regimens.

Dispensing & Storage

Specifies secure storage, access controls, recordkeeping for dispensed doses, tamper-evident packaging, and procedures for wasted or returned medication.

Monitoring & Audits

Describes routine inventory counts, discrepancy investigation workflows, internal audits, and corrective action plans following suspected diversion.

Reporting & Training

Outlines incident reporting to law enforcement, licensing boards, and the DEA as required; and staff training frequency and documentation.

Step-by-Step: Adopting or Updating the Policy

Follow a clear sequence to draft, review, approve, and train staff on the policy to ensure consistent implementation.

01

Draft Policy: Draft using current regulations and institutional needs.
02

Internal Review: Legal, pharmacy, and clinical leaders review content.
03

Approve & Sign: Authorized leadership signs and dates the final version.
04

Train Staff: Deliver training and retain attendance records.

Where to File and How to Route the Policy

Designate official storage locations and distribution channels so the policy is accessible and version-controlled.

Policy Repository: Store final signed policy in the institutional policy management system.
Medical Records: Attach policy reference in controlled-substance sections of medical records as required.
Compliance Office: Provide signed copy to compliance and pharmacy leadership for audit readiness.
Employee Files: File training acknowledgements in personnel records.

How to Configure an Electronic Workflow for Policy Approval

Set up a multi-step e-approval route that enforces required reviewers and captures an audit trail for each action.

Field	Configuration
Reviewers	Require pharmacy, legal, medical director
Authentication	Use MFA or enterprise SSO where possible
Version Control	Enable automatic version numbering and archive previous versions
Retention Setting	Set retention per records policy and HIPAA rules

Technical Requirements for Digital Completion and Signing

Choose platforms that support secure signatures, audit trails, and access controls aligned with institutional policies.

File Formats: Support PDF and DOCX
Integrations: Connects to EHR and cloud storage
Authentication: Supports SSO and MFA

Required Security and Compliance Controls

Encryption: TLS 1.2/1.3 in transit, AES-256 at rest

HIPAA BAA: BAA required for PHI handling

Audit Trail: Timestamps, IPs, action history

Access Controls: Role-based permissions required

Two-Factor: MFA for privileged accounts

Retention: Configurable retention policies

Consequences of an Incomplete or Noncompliant Policy

Criminal Liability: Prosecution under the Controlled Substances Act

Civil Sanctions: Fines and administrative penalties

License Action: Professional license suspension or revocation

HIPAA Breach: Civil penalties and corrective action

Civil Litigation: Malpractice or wrongful-death claims

Reputational Harm: Patient trust and accreditation risk

Common Mistakes to Avoid When Preparing the Policy

Using vague prescribing language that leaves clinical discretion undefined and creates inconsistent practice across providers.
Failing to specify inventory reconciliation frequency and method, which undermines investigations after discrepancies are found.
Not including PDMP checks or state-specific reporting requirements, exposing the facility to regulatory enforcement actions.
Allowing unsigned or undated approvals, making it difficult to prove authorization and version validity during audits.

Typical Timelines and Review Frequency

Establish clear dates and review cycles so the policy remains current with evolving law, clinical guidance, and accreditation standards.

Effective Date:

Enter MM/DD/YYYY for policy activation

Initial Training Window:

Complete training within 30 days of issue

Inventory Reconciliation:

Perform monthly or more frequently as required

Annual Review:

Review and update policy at least yearly

Incident Reporting:

Report suspected diversion immediately

eSignature Vendors: Pricing and Feature Snapshot for Policy Signing

Comparing basic pricing and key capabilities helps select a signing platform that supports security, HIPAA, and high-volume workflows.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by vendor	Varies by vendor	Varies by vendor	Varies by vendor
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies	Varies	Varies

Frequently Asked Questions About the Healthcare Narcotics Policy

Answers to common questions about drafting, signing, storing, and updating narcotics policies in U.S. healthcare settings.

Need help? Contact support

Are electronic signatures legally binding?
Yes. Electronic signatures meet legal validity under the ESIGN Act (15 U.S.C. §7001) and UETA where adopted, provided intent, consent, attribution, and reliable record retention are present.
Do I need a BAA for e-signatures?
If the signature process will handle protected health information, a Business Associate Agreement is required under HIPAA prior to using a vendor for signing PHI.
Who must sign the policy?
Authorized organizational leaders—typically the medical director, pharmacy director, and chief compliance officer—should sign to evidence approval and accountability.
How often should the policy be reviewed?
Review at least annually or sooner after regulatory changes, sentinel events, audits, or major changes in prescribing practice or technology.
What if a state requires additional steps?
Incorporate state-specific requirements such as PDMP query rules and reporting thresholds; consult state boards or counsel for mandated actions.
How do I revoke or update a signed policy?
Issue a formally dated revision, obtain required approvals, and retain prior versions in the archive; communicate changes and retrain staff as needed.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now